These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8607880)
21. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis. Zhou L; He X; Gao B; Xiong S J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170 [TBL] [Abstract][Full Text] [Related]
22. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3. Seko Y; Yagita H; Okumura K; Azuma M; Nagai R Cardiovasc Res; 2007 Jul; 75(1):158-67. PubMed ID: 17434153 [TBL] [Abstract][Full Text] [Related]
23. Cardioprotection of H2S by downregulating iNOS and upregulating HO-1 expression in mice with CVB3-induced myocarditis. Hua W; Chen Q; Gong F; Xie C; Zhou S; Gao L Life Sci; 2013 Dec; 93(24):949-54. PubMed ID: 24140888 [TBL] [Abstract][Full Text] [Related]
24. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Li K; Xu W; Guo Q; Jiang Z; Wang P; Yue Y; Xiong S Circ Res; 2009 Aug; 105(4):353-64. PubMed ID: 19608981 [TBL] [Abstract][Full Text] [Related]
25. Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus b3. Seko Y; Takahashi N; Yagita H; Okumura K; Yazaki Y J Pathol; 1997 Sep; 183(1):105-8. PubMed ID: 9370955 [TBL] [Abstract][Full Text] [Related]
26. Viral genomic detection in the hearts of C3H/He mice with experimental Coxsackievirus B3 myocarditis by gene amplification using the polymerase chain reaction. Koide H; Kitaura Y; Deguchi H; Ukimura A; Kawamura K; Hirai K Jpn Circ J; 1992 Feb; 56(2):148-56. PubMed ID: 1312649 [TBL] [Abstract][Full Text] [Related]
27. Inducible nitric oxide synthase protection against coxsackievirus pancreatitis. Zaragoza C; Ocampo CJ; Saura M; Bao C; Leppo M; Lafond-Walker A; Thiemann DR; Hruban R; Lowenstein CJ J Immunol; 1999 Nov; 163(10):5497-504. PubMed ID: 10553076 [TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor. Yu XH; Li SJ; Chen RZ; Yang YZ; Zhang P Chin Med J (Engl); 2012 Jan; 125(1):50-5. PubMed ID: 22340465 [TBL] [Abstract][Full Text] [Related]
29. A non-cardiovirulent strain of coxsackievirus B3 causes myocarditis in mice with severe combined immunodeficiency syndrome. Hufnagel G; Chapman N; Tracy S Eur Heart J; 1995 Dec; 16 Suppl O():18-9. PubMed ID: 8682092 [TBL] [Abstract][Full Text] [Related]
30. Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis. Iwasaki A; Matsumori A; Yamada T; Shioi T; Wang W; Ono K; Nishio R; Okada M; Sasayama S J Am Coll Cardiol; 1999 Apr; 33(5):1400-7. PubMed ID: 10193745 [TBL] [Abstract][Full Text] [Related]
31. Coxsackievirus B3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes. Shen Y; Kan QC; Xu W; Chu YW; Xiong SD Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):1-9. PubMed ID: 19279353 [TBL] [Abstract][Full Text] [Related]
32. Impact of myocardial inflammation on cytosolic and mitochondrial creatine kinase activity and expression. Ebermann L; Piper C; Kühl U; Klingel K; Schlattner U; Siafarikas N; Zeichhardt H; Schultheiss HP; Dörner A Basic Res Cardiol; 2009 May; 104(3):247-57. PubMed ID: 19190956 [TBL] [Abstract][Full Text] [Related]
34. Initial weight and virus dose: two factors affecting the onset of acute coxsackievirus B3 myocarditis in C57BL/6 mouse--a histopathology-based study. Li M; Wang X; Xie Y; Xie Y; Zhang X; Zou Y; Ge J; Chen R Cardiovasc Pathol; 2013; 22(1):96-101. PubMed ID: 22784985 [TBL] [Abstract][Full Text] [Related]
35. Restricted usage of T-cell receptor V alpha genes in infiltrating cells in murine hearts with acute myocarditis caused by coxsackie virus B3. Seko Y; Yoshifumi E; Yagita H; Okumura K; Yazaki Y J Pathol; 1996 Mar; 178(3):330-4. PubMed ID: 8778340 [TBL] [Abstract][Full Text] [Related]
36. Effect of the angiotensin II receptor blocker olmesartan on the development of murine acute myocarditis caused by coxsackievirus B3. Seko Y Clin Sci (Lond); 2006 Mar; 110(3):379-86. PubMed ID: 16336207 [TBL] [Abstract][Full Text] [Related]
37. T-cell receptor V beta gene expression in infiltrating cells in murine hearts with acute myocarditis caused by coxsackievirus B3. Seko Y; Yagita H; Okumura K; Yazaki Y Circulation; 1994 May; 89(5):2170-5. PubMed ID: 8181142 [TBL] [Abstract][Full Text] [Related]
38. The viral genome in experimental murine Coxsackievirus B3 myocarditis: a Northern blotting analysis. Okada I; Matsumori A; Kawai C; Yodoi J; Tracy S J Mol Cell Cardiol; 1990 Sep; 22(9):999-1008. PubMed ID: 2177795 [TBL] [Abstract][Full Text] [Related]
39. Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice. Zell R; Markgraf R; Schmidtke M; Görlach M; Stelzner A; Henke A; Sigusch HH; Glück B Med Microbiol Immunol; 2004 May; 193(2-3):91-100. PubMed ID: 14513374 [TBL] [Abstract][Full Text] [Related]
40. Detection of Coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction. Weiss LM; Movahed LA; Billingham ME; Cleary ML Am J Pathol; 1991 Feb; 138(2):497-503. PubMed ID: 1847008 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]